Background: Maintaining a healthy lifestyle to reduce type 2 diabetes (T2D) risk is challenging and additional strategies for T2D prevention are needed. We evaluated several lipid control medications as potential therapeutic options for T2D prevention using tissue-specific predicted gene expression summary statistics in a two-sample Mendelian randomisation (MR) design. Methods: Large-scale European genome-wide summary statistics for lipids and T2D were leveraged in our multi-stage analysis to estimate changes in either lipid levels or T2D risk driven by tissue-specific predicted gene expression. We incorporated tissue-specific predicted gene expression summary statistics to proxy therapeutic effects of three lipid control medications [i.e.,...
It remains unclear whether the increased risk of new-onset type 2 diabetes (T2D) seen in statin user...
The global burden of type 2 diabetes (T2D) is increasing, partially facilitated by a sharp increase ...
Journal ArticleResearch Support, Non-U.S. Gov'tCopyright © 2015 by the American Diabetes Association...
textabstractBackground: Statin treatment and variants in the gene encoding HMG-CoA reductase are ass...
International audienceBACKGROUND: Statin treatment and variants in the gene encoding HMG-CoA reducta...
BACKGROUND: Statin treatment and variants in the gene encoding HMG-CoA reductase are associated with...
BACKGROUND: Statin treatment and variants in the gene encoding HMG-CoA reductase are associated with...
SummaryBackgroundStatin treatment and variants in the gene encoding HMG-CoA reductase are associated...
Statin treatment and variants in the gene encoding HMG-CoA reductase are associated with reductions ...
AIMS/HYPOTHESIS: The aim of this study was to use Mendelian randomisation (MR) to identify the causa...
PublishedCommentJournal ArticleThe topic of the side-effects of statin treatment is important and co...
It remains unclear whether the increased risk of new-onset type 2 diabetes (T2D) seen in statin user...
The global burden of type 2 diabetes (T2D) is increasing, partially facilitated by a sharp increase ...
Journal ArticleResearch Support, Non-U.S. Gov'tCopyright © 2015 by the American Diabetes Association...
textabstractBackground: Statin treatment and variants in the gene encoding HMG-CoA reductase are ass...
International audienceBACKGROUND: Statin treatment and variants in the gene encoding HMG-CoA reducta...
BACKGROUND: Statin treatment and variants in the gene encoding HMG-CoA reductase are associated with...
BACKGROUND: Statin treatment and variants in the gene encoding HMG-CoA reductase are associated with...
SummaryBackgroundStatin treatment and variants in the gene encoding HMG-CoA reductase are associated...
Statin treatment and variants in the gene encoding HMG-CoA reductase are associated with reductions ...
AIMS/HYPOTHESIS: The aim of this study was to use Mendelian randomisation (MR) to identify the causa...
PublishedCommentJournal ArticleThe topic of the side-effects of statin treatment is important and co...
It remains unclear whether the increased risk of new-onset type 2 diabetes (T2D) seen in statin user...
The global burden of type 2 diabetes (T2D) is increasing, partially facilitated by a sharp increase ...
Journal ArticleResearch Support, Non-U.S. Gov'tCopyright © 2015 by the American Diabetes Association...